Amgen "market perform," target price reduced
16.08.07 - Friedman,Billings,Ramsey &Co
NEW YORK, August 16 (newratings.com) - Analysts at Friedman Billings reiterate their "market perform" rating on Amgen Inc (AMGN). The target price has been reduced from $59 to $56.
Share Empfehlen Sie diesen Artikel einem Freund!
AMGN zu meinen Aktien hinzufügen und E-Mail Alerts auf Amgen abonnieren
News